ImmuCell (ICCC) Corporation announced that it has selected Olivier te Boekhorst as its next president and CEO. The company anticipates a start date of November 1 for te Boekhorst. te Boekhorst is currently an operating partner at ARCHIMED, and serves as chair of the board of SeqCenter, a Next Generation Sequencing laboratory where he previously served as CEO.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICCC: